<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<http://schema.org/SearchAction>
<http://www.genengnews.com/gen-news-highlights/novartis-pays-genmab-2m-to-tap-into-bispecific-antibody-technology/81246845/?kwrd=Novartis>